KAPOSI?S SARCOMA-ASSOCIATED HERPESVIRUS K1 SIGNALOSOME
卡波西肉瘤相关疱疹病毒 K1 信号体
基本信息
- 批准号:7349565
- 负责人:
- 金额:$ 6.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-05-01 至 2007-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Kaposi's sarcoma (KS) is a multifocal angiogenic tumor and appears to be a hyperplastic disorder caused, in part, by local production of inflammatory cytokines. The K1 lymphocyte receptor-like protein of KS-associated herpesvirus (KSHV) efficiently transduces extracellular signals to elicit cellular activation events through its cytoplasmic immunoreceptor tyrosine-based activation motif (ITAM). To further delineate K1-mediated signal transduction, we purified K1 signaling complexes and identified its cellular components. Upon stimulation, the K1 ITAM was efficiently tyrosine phosphorylated and subsequently interacted with cellular Src homology 2 (SH2)-containing signaling proteins Lyn, Syk, p85, PLC2, RasGAP, Vav, SH2 domain-containing protein tyrosine phosphatase ¿, and Grab2 through its phosphorylated tyrosine residues. Mutational analysis demonstrated that each tyrosine residue of K1 ITAM contributed to the interactions with cellular signaling proteins in distinctive ways. Consequently, these interactions led to the marked augmentation of cellular signal transduction activity, evidenced by the increase of cellular tyrosine phosphorylation and intracellular calcium mobilization, the activation of NF-AT and AP0-1 transcription factor activities, and the production of inflammatory cytokines. These results demonstrate that KSHV K1 effectively recruits a set of cellular SH2-containing signaling molecules to form the K1 signalosome, which elicits downstream signal transduction and induces inflammatory cytokine production.
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。卡波西肉瘤是一种多灶性血管生成性肿瘤,是一种增生性疾病,部分原因是局部产生炎性细胞因子。KS相关疱疹病毒(KSHV)的K1淋巴细胞受体样蛋白通过其胞质免疫受体酪氨酸激活基序(ITAM)有效地转导细胞外信号以引发细胞激活事件。为了进一步描述K1介导的信号转导,我们纯化了K1信号复合物并鉴定了其细胞组分。在刺激后,K1 ITAM被有效地酪氨酸磷酸化,随后通过其磷酸化的酪氨酸残基与含有细胞Src同源性2(SH 2)的信号传导蛋白林恩、Syk、p85、PLC 2、RasGAP、Vav、含有SH 2结构域的蛋白酪氨酸磷酸酶?和Grab 2相互作用。突变分析表明,K1 ITAM的每个酪氨酸残基以独特的方式与细胞信号蛋白相互作用。因此,这些相互作用导致细胞信号转导活性的显著增强,这通过细胞酪氨酸磷酸化和细胞内钙动员的增加、NF-AT和AP 0 -1转录因子活性的激活以及炎性细胞因子的产生来证明。这些结果表明,KSHV K1有效地招募了一组细胞内含有SH 2的信号分子,形成K1信号体,从而促进下游信号转导并诱导炎症细胞因子的产生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BOK-SOO LEE其他文献
BOK-SOO LEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BOK-SOO LEE', 18)}}的其他基金
SUPPRESSION OF LYTIC REACTIVATION OF KSHV BY K1 SIGNAL TRANSDUCTION
K1 信号转导抑制 KSHV 的裂解再激活
- 批准号:
6940186 - 财政年份:2003
- 资助金额:
$ 6.63万 - 项目类别:
相似海外基金
Use of a non-human primate model to define the role of T cell immune responses in persistent Kaposi sarcoma-associated herpesvirus infection and Kaposi sarcoma pathogenesis
使用非人灵长类动物模型来定义 T 细胞免疫反应在持续性卡波西肉瘤相关疱疹病毒感染和卡波西肉瘤发病机制中的作用
- 批准号:
10667986 - 财政年份:2023
- 资助金额:
$ 6.63万 - 项目类别:
Project 2: Clinical and molecular determinants of HIV-associated Kaposi Sarcoma progression under local standard-of-care therapy in Malawi and South Africa
项目 2:马拉维和南非当地标准护理治疗下 HIV 相关卡波西肉瘤进展的临床和分子决定因素
- 批准号:
10434864 - 财政年份:2020
- 资助金额:
$ 6.63万 - 项目类别:
Project 2: Clinical and molecular determinants of HIV-associated Kaposi Sarcoma progression under local standard-of-care therapy in Malawi and South Africa
项目 2:马拉维和南非当地标准护理治疗下 HIV 相关卡波西肉瘤进展的临床和分子决定因素
- 批准号:
10652401 - 财政年份:2020
- 资助金额:
$ 6.63万 - 项目类别:
Project 2: Clinical and molecular determinants of HIV-associated Kaposi Sarcoma progression under local standard-of-care therapy in Malawi and South Africa
项目 2:马拉维和南非当地标准护理治疗下 HIV 相关卡波西肉瘤进展的临床和分子决定因素
- 批准号:
10084558 - 财政年份:2020
- 资助金额:
$ 6.63万 - 项目类别:
Project 2: Clinical and molecular determinants of HIV-associated Kaposi Sarcoma progression under local standard-of-care therapy in Malawi and South Africa
项目 2:马拉维和南非当地标准护理治疗下 HIV 相关卡波西肉瘤进展的临床和分子决定因素
- 批准号:
10238161 - 财政年份:2020
- 资助金额:
$ 6.63万 - 项目类别:
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
(PQ5) 探索非洲卡波西肉瘤相关疱疹病毒流行地区艾滋病毒相关性和地方性小儿卡波西肉瘤之间的生物学差异
- 批准号:
9335144 - 财政年份:2017
- 资助金额:
$ 6.63万 - 项目类别:
The role of Ephrin-A2 receptor-tyrosinkinase in Kaposi sarcoma-associated herpesvirus infection
Ephrin-A2受体酪氨酸激酶在卡波西肉瘤相关疱疹病毒感染中的作用
- 批准号:
244312816 - 财政年份:2014
- 资助金额:
$ 6.63万 - 项目类别:
Research Grants
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
HIV 相关卡波西肉瘤和淋巴瘤的靶向治疗
- 批准号:
9334119 - 财政年份:2011
- 资助金额:
$ 6.63万 - 项目类别:
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
HIV 相关卡波西肉瘤和淋巴瘤的靶向治疗
- 批准号:
10548401 - 财政年份:2011
- 资助金额:
$ 6.63万 - 项目类别:
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
HIV 相关卡波西肉瘤和淋巴瘤的靶向治疗
- 批准号:
9978721 - 财政年份:2011
- 资助金额:
$ 6.63万 - 项目类别: